Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Earnings release
confidence 85%
filed 2026-05-19
Item 7.01
Item 7.01 explicitly directs readers to "See Item 2.02," which is the standard 8-K item for disclosure of results of operations and financial condition. The filing date of 2026-05-19 and the reference structure indicate this is an earnings release disclosure. The exhibits (99.1 and 99.2) are typical attachments for earnings announcements. While Item 7.01 itself contains only a Regulation FD disclaimer, the substantive disclosure is in Item 2.02.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Rush Enterprises' 2026 Annual Meeting of Shareholders. The filing presents voting outcomes for three proposals: election of nine directors, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are the core content, making this unambiguously a shareholder vote results disclosure.
View raw filing on EDGAR →
Dilutive issuance
confidence 95%
filed 2026-05-19
Item 1.01
GeoVax Labs entered into a securities purchase agreement on May 18, 2026 for an unregistered private placement of pre-funded warrants and common warrants to purchase up to 6,081,081 shares of common stock, raising approximately $2.7 million in net proceeds. The securities were issued under Section 4(a)(2) and Regulation D exemptions, and the filing explicitly notes the securities "have not been registered under the Securities Act." This is a classic dilutive issuance—an unregistered equity offering that will substantially increase share count upon warrant exercise, materially affecting existing shareholders.
View raw filing on EDGAR →
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 3.02
Item 3.02 discloses unregistered sales of equity securities—specifically Pre-Funded Warrants and Common Warrants issued under Section 4(a)(2) and Rule 506(b) of Regulation D. This is a classic private placement of warrant instruments that will dilute existing shareholders upon exercise. The filing explicitly references warrant forms and future issuance of Common Warrant Shares, indicating a capital raise through dilutive equity instruments.
View raw filing on EDGAR →
Dilutive issuance
confidence 72%
filed 2026-05-19
Item 7.01
The filing discloses pricing of an "Offering" via press release on May 18, 2026, filed under Item 7.01 (Regulation FD Disclosure). While the specific terms are not detailed in the excerpt, the reference to "pricing of the Offering" strongly suggests an equity or convertible securities issuance. The use of Item 7.01 rather than Item 3.02 (Unregistered Sales) is consistent with a registered offering, but the disclosure of pricing is material to investors assessing potential dilution and capital structure changes.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses financial results for Q1 2026 (three months ended March 31, 2026) via a press release and conference call transcript, both attached as exhibits. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
Earnings release
confidence 75%
filed 2026-05-19
Item 7.01
Item 7.01 incorporates by reference "the information under Item 2.02 above," which is the standard Item for earnings releases and financial results disclosure. The exhibits (99.1 and 99.2) are typical of earnings release attachments. The Regulation FD safe-harbor language is standard for earnings disclosures. While the Item 7.01 text itself is boilerplate, the cross-reference to Item 2.02 indicates the material event is an earnings release.
View raw filing on EDGAR →
M&A activity
confidence 92%
filed 2026-05-19
Item 1.01
Eton entered into a material definitive supply and distribution agreement on May 18, 2026 granting exclusive U.S. commercialization rights to IMPAVIDO® (miltefosine) from Knight Therapeutics. The agreement involves $4.25 million in fixed fees over the initial term (through March 31, 2032), up to $4.0 million in milestone payments tied to cumulative net sales, and ongoing royalties of 50–55% of net sales. This constitutes a material acquisition of commercial rights to an orphan drug product with existing 2025 U.S. sales of $8.1 million, directly expanding Eton's product portfolio and revenue streams.
View raw filing on EDGAR →
M&A activity
confidence 85%
filed 2026-05-19
Item 2.01
The filing discloses completion of a supply and distribution agreement for U.S. commercialization rights to IMPAVIDO® (miltefosine), a pharmaceutical product. This represents acquisition of material commercial rights that would affect the company's revenue-generating capabilities and strategic positioning. The reference to Item 1.01 (entry into agreement) and Item 2.01 (completion) indicates a material transaction in the company's business operations.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Cathay General Bancorp's May 18, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on four matters: election of four Class III directors, advisory approval of executive compensation, frequency of future advisory votes on compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (for, against, abstain, broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Waterstone Financial's 2026 Annual Meeting of Shareholders held on May 19, 2026. The filing presents detailed voting tallies for four proposals: election of three directors, ratification of auditors (Forvis Mazars, LLP), advisory approval of executive compensation, and advisory vote on compensation voting frequency. This is a quintessential Item 5.07 shareholder_vote_results event, and the outcomes are material to investors as they reflect shareholder approval of board composition, auditor selection, and executive compensation arrangements.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 8.01
The filing discloses a sale of three nonperforming loans via press release on May 19, 2026. While loan sales can be routine portfolio management, the fact that Alerus Financial chose to announce this via 8-K Item 8.01 suggests materiality to investors. However, without details on the dollar amount, impact on asset quality, or strategic significance, the event does not clearly fit the more specific categories (e.g., material_impairment would require a write-down or charge; ma_activity typically involves larger acquisitions or dispositions). The disclosure is material enough to warrant 8-K filing but ambiguous in nature, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 8.01
The disclosure announces a ticker symbol change from an unspecified prior symbol to "KWY" on the NYSE effective May 19, 2026, in connection with a company name change. While ticker changes are administrative in nature, this event is material to investors as it affects how the security is identified and traded in the market. The change does not fit neatly into the more specific event categories (not a delisting, not an M&A event, not a restatement), making "other_material" the appropriate classification.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses Sypris Solutions' financial results for the first quarter ended April 5, 2026, announced on May 19, 2026, with the full press release attached as Exhibit 99. This is a standard quarterly earnings release disclosed under Item 2.02, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 7.01
The filing discloses financial results for the first quarter ended April 5, 2026, with the full text of the press release attached as Exhibit 99. This is a standard earnings release announcement, which is material to investors as it provides periodic financial performance information. The Item 7.01 (Regulation FD Disclosure) classification is typical for earnings releases furnished under Regulation FD.
View raw filing on EDGAR →
M&A activity
confidence 85%
filed 2026-05-19
Item 7.01
The Company entered into a Memorandum of Understanding with the County of Maui regarding the sale or lease of real property and water infrastructure assets in West Maui and Upcountry Maui. Although the MOU is non-binding, it represents a material disposition of assets (water-related assets and real property) that would affect a reasonable investor's assessment of the Company's strategic direction and asset base. The disclosure emphasizes this as "an important milestone in the Company's efforts to sell certain assets" and notes the County has "initiated budget allocations toward the potential purchase," indicating substantive progress toward a material transaction.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
The filing discloses financial results for the fiscal quarter ended March 31, 2026 via a press release issued on May 14, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 7.01
Granite Construction announced pricing of a $600 million private offering of senior notes due 2034. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations, it does not fit cleanly into the dilutive_issuance category (which focuses on equity securities) nor any other specific event type. The disclosure is material as it represents a significant financing activity, but the taxonomy lacks a dedicated debt issuance category.
View raw filing on EDGAR →
M&A activity
confidence 85%
filed 2026-05-19
Item 8.01
The filing discloses that WBD's subsidiaries have commenced consent solicitations to amend indentures governing outstanding notes in connection with the pending acquisition of WBD by Paramount Skydance Corporation. While the primary focus is the consent solicitation mechanics, the disclosure is fundamentally tied to and conditioned upon the material acquisition transaction. The forward-looking statements section explicitly references "the acquisition of WBD (the 'Acquisition') by Paramount Skydance Corporation" as a central transaction affecting the company's financial obligations and future operations, making this a material M&A-related event.
View raw filing on EDGAR →
Exec Compensation
confidence 85%
filed 2026-05-19
Item 5.02
The disclosure centers on stockholder approval of amendments to the 2022 Omnibus Equity Award Plan and the 2020 Employee Stock Purchase Plan, increasing share reserves by 2.8 million and 500,000 shares respectively. These are compensatory arrangements affecting equity issuance capacity for officers and employees, fitting the exec_compensation category. The material increase in authorized shares for equity awards makes this material to investors assessing dilution and compensation policy.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from DHI Group's Annual Meeting held May 15, 2026, covering five proposals: election of two Class I directors (Art Zeile and Elizabeth Salomon), ratification of RSM US LLP as auditor, advisory vote on named executive officer compensation, approval of amendments to the 2022 Omnibus Equity Award Plan and 2020 Employee Stock Purchase Plan. All proposals were approved. This directly matches Item 5.07 (Submission of Matters to Vote of Security Holders) and is material to investors as it reflects governance decisions and shareholder approval of equity plans.
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
Healthcare Realty Trust entered into a $400 million senior unsecured delayed draw term loan facility on May 15, 2026, with Wells Fargo as administrative agent and a syndicate of major lenders. While this is a financing arrangement rather than a traditional M&A transaction, it represents a material definitive agreement that materially affects the company's capital structure and financial obligations. The substantial size, multi-year maturity (May 2029), and syndicated nature of the facility make it a material event affecting investor assessment of the registrant's financial position and liquidity.
View raw filing on EDGAR →
Other material
confidence 45%
filed 2026-05-19
Item 2.03
Item 2.03 discloses creation of a direct financial obligation, with details incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. Item 1.01 typically covers material acquisitions or dispositions, which would suggest ma_activity, but could also relate to debt issuance or other financial arrangements. The materiality is clear given the Item 2.03 disclosure, but the event type remains ambiguous without the referenced content.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $920.2 million across multiple tranches with varying maturities (2026–2036) and rate structures. While the Bank explicitly states it "has not made a judgment as to the materiality of these consolidated obligation bonds," the aggregate principal amount and the nature of debt issuance—a core funding mechanism for a Federal Home Loan Bank—constitute a material event affecting the registrant's financial position. This does not fit neatly into the covenant_breach taxonomy (no breach disclosed) but represents a material creation of direct financial obligations as contemplated by Item 2.03.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling approximately $445 million across multiple issuances with varying maturities (2028–2056) and rate structures. While Item 2.03 is technically about creation of direct financial obligations, this disclosure is most accurately characterized as a material debt issuance event. The bonds are joint and several obligations of the FHLBanks and represent a significant financial commitment, but the filing does not fit cleanly into the covenant_breach taxonomy (no breach alleged) or other more specific event types, making other_material the most appropriate classification.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (debt securities) totaling $850 million across three tranches with trade dates of 5/15/2026 and 5/19/2026. While Item 2.03 is the designated item for debt issuances, the taxonomy lacks a specific "debt_issuance" category. The filing explicitly states "consolidated obligations issuance is material to the Bank," and these obligations represent direct financial liabilities. This is classified as "other_material" rather than "covenant_breach" (which addresses defaults) because it represents routine debt capital-raising activity, albeit material in amount, that does not fit the more specific event categories provided.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $2.185 billion across multiple tranches with varying maturities, rates, and call features. While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing discloses routine debt issuances by a Federal Home Loan Bank in the ordinary course of business—a material but recurring funding activity. The disclosure emphasizes joint and several liability across all FHLBanks and provides detailed Schedule A information on each issuance, making it material to investors but not fitting the specific covenant_breach or other narrower event categories.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the issuance of consolidated obligation bonds totaling approximately $260 million across nine separate debt securities issued on trade dates of 5/13/2026 and 5/15/2026. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although consolidated obligations issuance is material to the Bank, we have not made a judgment as to the materiality of any particular consolidated obligation or obligations." The disclosure is routine debt issuance reporting for a Federal Home Loan Bank, which regularly accesses capital markets through consolidated obligations. This does not fit the specific event types of covenant_breach (no breach indicated), ma_activity (no acquisition/merger), or other more specific categories—it is a material but routine debt issuance disclosure.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 2.03
This Item 2.03 disclosure reports the issuance of Consolidated Bonds (debt securities) totaling $81 million across six bond offerings on trade date 5/13/2026. While Item 2.03 is technically designated for "Creation of a Direct Financial Obligation," the filing itself explicitly states "although Consolidated Obligations issuance is material to the FHLB, we have not made a judgment as to the materiality of any particular Consolidated Obligation or Obligations." The disclosure is routine debt issuance reporting by a Federal Home Loan Bank, not a material event in the traditional 8-K sense (no covenant breach, no going-concern issue, no acceleration of obligations). This is a borderline case—the issuance is material in aggregate to the FHLB's operations, but the filing's own language suggests individual issuances are routine capital-markets activity. Classified as other_material rather than covenant_breach because no triggering event or financial stress is disclosed.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $960 million across five separate issuances in May 2026. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure does not fit cleanly into the standard taxonomy categories. The event is a routine debt issuance by a government-sponsored enterprise (Federal Home Loan Bank), not a covenant breach, M&A activity, or other more specific event type. This is best classified as other_material given its materiality to the registrant's funding operations and balance sheet, despite being a standard capital markets activity.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 2.03
This disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While Item 2.03 typically captures covenant breaches or material debt arrangements, this filing describes routine debt issuance activity that is material to the Bank's operations but does not fit cleanly into the covenant_breach category (no breach or default is disclosed). The Bank explicitly states "consolidated obligations issuance is material to the Bank," and Schedule A details committed issuances, making this a material event that warrants disclosure but falls outside the more specific event-type categories.
View raw filing on EDGAR →
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The disclosure centers on stockholder approval of an amendment to the AtriCure 2023 Stock Incentive Plan, increasing available shares from 4.5 million to 6 million. This is a compensatory arrangement disclosure under Item 5.02(e), as it involves shareholder approval of a material equity plan amendment that directly affects the compensation vehicles available to directors, officers, and employees. The plan's stated purpose is to provide equity incentives and attract key personnel.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is Item 5.07 disclosing the results of AtriCure's Annual Meeting of Stockholders, including voting outcomes on five proposals: director elections, auditor ratification, stock plan amendments, and advisory compensation vote. All proposals passed with substantial majorities, and the filing provides detailed vote tallies for each director nominee and proposal, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $50 million across three tranches (maturing 2027–2031 with coupons of 4.0–4.35%). While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing describes routine debt issuance by a Federal Home Loan Bank in the capital markets—a material but recurring operational activity that does not fit the specific covenant_breach taxonomy (which implies default or acceleration). The Bank explicitly notes that "consolidated obligations issuance is material to the Bank" but disclaims judgment on individual issuances' materiality, suggesting this is standard disclosure practice rather than an extraordinary event.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 8.01
Roblox announced a $3 billion share repurchase program authorized by its Board of Directors. While share buybacks are material capital allocation decisions that affect shareholder value and earnings per share, this disclosure does not fit neatly into the more specific event categories (it is not an earnings release, M&A activity, executive change, or financial restatement). The authorization itself—distinct from actual repurchases—is a significant corporate action that would inform investor assessment of capital strategy, but the taxonomy lacks a dedicated "capital allocation" or "buyback authorization" category.
View raw filing on EDGAR →
Earnings release
confidence 95%
filed 2026-05-19
Item 2.02
Novelis Inc. issued a press release on May 19, 2026 reporting financial results for its fiscal year ended March 31, 2026, with the press release attached as Exhibit 99.1. The Item 2.02 disclosure explicitly states the company is furnishing results of operations and financial condition, which is the standard format for earnings releases. The detailed non-GAAP reconciliations (Adjusted EBITDA, Adjusted Free Cash Flow, Net Income Excluding Special Items) are typical of annual earnings disclosures.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear Item 5.07 disclosure of shareholder meeting results held on May 19, 2026. The filing reports voting outcomes on three proposals: election of nine trustees, ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The detailed vote tallies (For, Against/Withheld, Abstentions, Broker Non-Votes) for each proposal are the core content of the filing, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 1.01
This Item 1.01 discloses entry into multiple material definitive agreements that collectively signal severe financial distress: a $6M judgment settlement with ACM requiring $2.5M cash plus equity issuance, standstill agreements with CFI and Labrys on convertible notes, and a settlement with Reimer Plaintiffs involving 39M share issuance capped at $2M value. While these are technically separate agreements, they do not fit cleanly into the M&A taxonomy (no acquisition, merger, or change of control) and collectively represent a restructuring of material liabilities through dilutive equity issuances and creditor standstills—a pattern more characteristic of financial distress than a traditional material transaction.
View raw filing on EDGAR →
Covenant Breach
confidence 65%
filed 2026-05-19
Item 2.03
Item 2.03 discloses a direct financial obligation of $2,500,000 under the ACM Letter Agreement and related Confession of Judgment documents. While the Item 2.03 caption itself does not explicitly state a covenant breach, the reference to a "Confession of Judgment" — a legal instrument typically filed when a debtor acknowledges a debt and waives the right to defend against it — suggests an accelerated or triggered financial obligation. This is a material direct obligation that would affect investor assessment of the registrant's financial position and liquidity.
View raw filing on EDGAR →
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 3.02
The filing discloses unregistered sales of equity securities under Item 3.02, specifically: (1) issuance to ACM in satisfaction of a judgment obligation under Section 4(a)(2) and Rule 506 of Regulation D, and (2) issuance of Reimer Settlement Shares under Section 3(a)(10). These are classic dilutive equity issuances used to settle obligations, which materially affect shareholder equity and voting power.
View raw filing on EDGAR →
Exec departure
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses two executive departures: Mohan Ananda's resignation from the Board of Directors (effective May 10, 2026) and Shachi Singh's resignation as Chief Legal Officer & General Counsel (effective April 28, 2026). Both resignations are stated to be unrelated to disagreements with the Company. The departure of a named executive officer (CLO) and a director are material events that would affect a reasonable investor's assessment of the registrant's governance and leadership continuity.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 8.01
This Item 8.01 disclosure involves two material events: (1) a court order vacating a temporary restraining order and scheduling a fairness hearing for a settlement agreement that conditions issuance of settlement shares, and (2) termination of placement agent agreements with Aegis Capital in exchange for $2 million in consideration securities contingent on an uplisting or December 31, 2026. While the Aegis termination resembles a dilutive issuance, the disclosure centers on settlement litigation and contingent equity arrangements that do not fit cleanly into the standard taxonomy categories. The material nature is evident from the court proceedings and the $2 million contingent equity commitment affecting future capitalization.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 8.01
This disclosure concerns a proxy contest at Vaxart's 2026 Annual Meeting, where the Company is urging shareholders to support its six director nominees against three dissident candidates nominated by a shareholder. While proxy contests and shareholder activism can materially affect governance and strategic direction, this Item 8.01 disclosure does not fit neatly into the specific event categories (e.g., shareholder_vote_results applies to vote outcomes, not pre-vote solicitations). The disclosure is material because it signals potential control challenges and governance uncertainty, but the absence of a dedicated taxonomy category for proxy contests or shareholder activism makes "other_material" the most appropriate classification.
View raw filing on EDGAR →
M&A activity
confidence 85%
filed 2026-05-19
This 8-K discloses the consummation of an initial public offering (IPO) on May 18, 2026, with the registration statement declared effective on May 14, 2026. The Company raised $150 million in gross proceeds from the sale of 15 million units at $10.00 per unit, plus an additional $5.375 million from a concurrent private placement of warrants. While technically an IPO rather than a traditional M&A transaction, the filing is structured around Item 1.01 (Entry into a Material Definitive Agreement) and involves multiple material agreements (underwriting, warrant, registration rights, etc.) that constitute the foundational capital-raising event. The closest taxonomy fit is ma_activity, as this represents a material capital transaction and change of control event (transition from private to public company), though the event could also be characterized as a dilutive_issuance given the warrant components and private placement structure.
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 7.01
The filing discloses a letter to stockholders regarding "the potential acquisition of certain assets and intellectual property of BullionFX Ltd." This describes entry into or contemplation of a material acquisition transaction. Although the language uses "potential," the fact that the company issued a formal stockholder letter and filed it on 8-K indicates materiality. The acquisition of assets and IP from another entity constitutes M&A activity under Item 1.01/2.01 framework, even if still in preliminary stages.
View raw filing on EDGAR →
Shareholder vote
confidence 45%
filed 2026-05-19
The filing discloses a Board-approved change in investment sub-adviser (King Street Sub-Adviser replacing Octagon Credit Investors) that requires shareholder approval at a special meeting scheduled for July 30, 2026. While the filing is primarily a solicitation of proxies (Item 8.01, Other Events) announcing the proposed change and calling for shareholder vote, it does not yet report actual vote results. The material event is the proposed sub-adviser change and the upcoming shareholder vote, which is significant to investors in this closed-end fund.
View raw filing on EDGAR →
Shareholder vote
confidence 45%
filed 2026-05-19
The filing discloses a Board-approved proposal to add PineBridge as an additional investment sub-adviser, subject to shareholder approval at a special meeting scheduled for July 30, 2026. However, this is a pre-vote disclosure (Item 8.01, Other Events) announcing the proposal and soliciting material, not a report of actual shareholder vote results. The checkbox for "Soliciting material pursuant to Rule 14a-12" is marked, confirming this is proxy solicitation material rather than a vote outcome. The event is material as it involves a significant change to the Fund's investment strategy and sub-advisory structure, but the event_type is ambiguous—this could also be classified as "other_material" since it does not fit the shareholder_vote_results category (which reports results after voting has occurred).
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 5.03
This disclosure reports a shareholder-approved amendment to the Company's charter extending the business combination deadline by 12 months (from June 16, 2026 to June 16, 2027). While Item 5.03 covers charter amendments, this is a SPAC extension event that materially affects the registrant's timeline and obligations. The event is material to investors assessing the SPAC's ability to complete a business combination, but does not fit neatly into the specific taxonomy categories (it is neither a routine bylaw amendment nor a traditional M&A activity, going-concern issue, or executive change).
View raw filing on EDGAR →
Shareholder vote
confidence 95%
filed 2026-05-19
Item 5.07
This Item 5.07 discloses the results of an Extraordinary General Meeting (EGM) held on April 10, 2026, where shareholders voted on a Charter Amendment Proposal. The filing reports voting tallies (3,308,619 FOR, 2,861,341 AGAINST, 0 ABSTAIN) and notes that 5,333,287 ordinary shares were tendered for redemption in connection with the vote. This is a classic shareholder vote results disclosure, material to investors as it reflects shareholder approval of corporate governance changes and capital structure adjustments at a SPAC.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 8.01
The Sponsor entered into an assignment of economic interest agreement with a third party to secure votes for a Charter Amendment Proposal in exchange for transferring 50,000 Class B shares post-business combination. This represents a material arrangement affecting share ownership, voting control, and governance of the SPAC, but does not fit neatly into the standard taxonomy categories (not an appointment, departure, M&A completion, or other defined event type). The transaction involves material consideration and governance implications warranting disclosure.
View raw filing on EDGAR →